Clinical trial of sustained-release bezafibrate in patients with severe hypertriglyceridaemia in the US

Trial Profile

Clinical trial of sustained-release bezafibrate in patients with severe hypertriglyceridaemia in the US

Not yet recruiting
Phase of Trial: Phase III

Latest Information Update: 10 Dec 2013

At a glance

  • Drugs Bezafibrate (Primary)
  • Indications Hypertriglyceridaemia
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 10 Dec 2013 New trial record
    • 11 Nov 2013 An IND was submitted to the US FDA on 27 September 2013 and cleared by the FDA in November 2013, according to a Tribute Pharmaceuticals Canada Inc media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top